Bank of the West’s GSK GSK Stock Holding History

Bank of the West’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,046	Closed	-$318K	–	298
2017 Q1	$318K	Buy	6,046 +148	+3%	+$7.51K	0.04%	246
2016 Q4	$284K	Sell	5,898 -429	-7%	-$21.2K	0.04%	254
2016 Q3	$341K	Buy	6,327 +1,781	+39%	+$97.7K	0.05%	239
2016 Q2	$246K	Buy	+4,546	New	+$239K	0.04%	272
2015 Q4	–	Sell	-8,485	Closed	-$407K	–	287
2015 Q3	$407K	Buy	8,485 +431	+5%	+$22.4K	0.06%	208
2015 Q2	$419K	Sell	8,054 -64	-0.8%	-$3.6K	0.06%	206
2015 Q1	$468K	Buy	+8,118	New	+$465K	0.07%	197
2014 Q4	–	Sell	-8,044	Closed	-$462K	–	288
2014 Q3	$462K	Buy	8,044 +488	+6%	+$29.9K	0.08%	181
2014 Q2	$505K	Sell	7,556 -1,395	-16%	-$94.4K	0.08%	173
2014 Q1	$598K	Buy	8,951 +65	+0.7%	+$4.39K	0.1%	155
2013 Q4	$593K	Buy	8,886 +2,800	+46%	+$182K	0.09%	163
2013 Q3	$382K	Hold	6,086	–	–	0.07%	172
2013 Q2	$380K	Buy	+6,086	New	+$386K	0.07%	171

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of the West's GSK Position: Q2 2017 in Review

Bank of the West sold out of GSK (GSK) in Q2 2017, closing a stake of 6,046 shares — an estimated $318K sold.

Bank of the West first reported a position in GSK in Q2 2013 and held it in 13 quarters. The position peaked at $598K in Q1 2014. 780 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Bank of the West reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
Bank of the West sold 6,046 GSK shares in Q2 2017, an estimated $318K.
Bank of the West first reported a position in GSK in Q2 2013 and held it in 13 quarters.
Bank of the West's GSK position peaked at $598K in Q1 2014.
780 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Bank of the West's 13F filing for Q2 2017, filed 12 Jul 2017.